Clinical Trial Update: 99mTc-QULIC-5-P1 SPECT Imaging in Patients With Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial update describing the evaluation of the 99mTc-QULIC-5-P1 SPECT imaging agent in patients with prostate cancer to visualize PSMA expression.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 99mTc-QULIC-5-P1

Snippet

Sponsor: First Affiliated Hospital of Chongqing Medical University | Conditions: Prostate Cancer Stage, PSMA | EARLY_Phase 1 | Status: RECRUITING